Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2	2	5	14	16	5
Market Cap Growth	-74.30%	-63.48%	-62.43%	-12.96%	244.39%	-24.67%
Enterprise Value	-4	-7	-7	-10	2	-2
PE Ratio	-	-0.17	-0.44	-1.02	-1.77	-0.51
PS Ratio	-	-	-	-	-	215.01
PB Ratio	0.41	0.24	0.47	0.62	1.20	0.79
P/FCF Ratio	-0.17	-0.17	-0.42	-1.14	-1.76	-0.52
P/OCF Ratio	-0.17	-0.17	-0.42	-1.14	-1.77	-0.52
EV/Sales Ratio	-	-	-	-	-	-92.90
EV/EBITDA Ratio	0.52	0.62	0.58	0.78	-0.22	0.22
EV/EBIT Ratio	0.51	0.61	0.57	0.77	-0.22	0.22
EV/FCF Ratio	0.48	0.61	0.54	0.86	-0.22	0.22
Debt / Equity Ratio	-	0.00	0.02	0.01	0.05	0.09
Debt / EBITDA Ratio	-	0.00	-0.02	-0.02	-0.07	-0.06
Debt / FCF Ratio	-	0.00	-0.01	-0.02	-0.07	-0.06
Quick Ratio	5.18	5.20	6.10	7.86	6.51	3.71
Current Ratio	5.48	5.71	6.42	8.06	6.91	3.88
Asset Turnover	0	0	0	0	0	0.00
Interest Coverage	-	-	-	-	-8793.00	-
Return on Equity (ROE)	-123.20%	-134.70%	-75.50%	-49.50%	-60.50%	-102.60%
Return on Assets (ROA)	-98.60%	-105.90%	-64.80%	-44.80%	-51.40%	-81.20%
Return on Capital (ROIC)	-168.29%	-139.39%	-104.12%	-60.79%	-64.38%	-143.42%
Earnings Yield	-408.48%	-582.98%	-225.78%	-98.17%	-56.55%	-197.29%
FCF Yield	-438.05%	-579.10%	-240.93%	-87.99%	-56.73%	-193.06%
Buyback Yield / Dilution	-300.98%	-83.32%	-6.30%	-179.70%	-895.43%	-259.78%
Total Shareholder Return	-300.98%	-83.32%	-6.30%	-179.70%	-895.43%	-259.78%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).